RNA-seq of human breast cancer cell line MDA-MB-231 treated with STM2457 against untreated controls

ABSTRACT: Here, we aim to investigate if catalytic inhibition of the m6A methyltransferase METTL3 by the small-molecule STM2457 may be a viable treatment option for TNBC.

INSTRUMENT(S): Illumina NovaSeq 6000, PerkinElmer

ORGANISM(S): Homo sapiens

SUBMITTER: Alessandro Fatica 

PROVIDER: E-MTAB-13184 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress